Outline of CellaVision AB's Annual General Meeting (AGM) 2007


  • To adopt the Statement of Income and Balance Sheet for the parent company and the Group for the year 2006. 
  • That the total deficit of SEK -12,532,402 shall be balanced against the share premium reserve, which will be reduced by an equivalent amount. 
  • To discharge the Board of Directors and the Chief Executive Officer from liability. 
  • That the Board of Directors shall consist of five regular members and no alternatives. 
  • To re-elect the following Directors:
    - Christer Fåhraeus
    - Lars Gatenbeck
    - Niels Freiesleben
    - Sven-Åke Henningsson 
  • And to elect the following Director to the Board:
    - Torbjörn Kronander 
  • To elect Lars Gatenbeck as the Chairman of the Board. 
  • That the remuneration to the Chairman of the Board shall amount to SEK 140,000 (140,000). The remuneration to other directors shall amount to SEK 70,000 (70,000) each, in total SEK 280,000 (350,000). Remuneration to the auditors shall be paid on a current account basis. 
  • To approve the Board of Directors' recommendation to resolve to issue a maximum of 3,000,000 shares. If the authorization is fully implemented, there will be a maximum of 11.2 percent dilution of share capital.
The General Annual Meeting's complete decisions as accounted for above are available at the company address, Ideon Science Park in Lund, and are sent to those share holders who request it.

Lund April 26, 2007

CellaVision AB (publ)
Board of Directors
 
Read the CEO statement by following the link below.
 
For more information, please contact:
Yvonne Mårtensson, CEO, +46 708-33 77 82

Attachments

CEO Statement 2007